Abstract: Embodiments of the present disclosure relate to a method and system for producing refined hydrocarbons from waste plastics. The method and system for producing refined hydrocarbons from waste plastics according to the embodiments of the present disclosure may minimize formation of an ammonium chloride salt (NH4Cl) and may prevent an adhesion phenomenon of impurity particles in a reactor in a refining process of waste plastic pyrolysis oil containing impurities including chlorine and nitrogen. In addition, the method and system for producing refined hydrocarbons according to the present disclosure may have excellent refining efficiency and may implement a long-term operation of a process because deactivation of a catalyst used in the process is prevented, and may produce, from waste plastics, refined hydrocarbons including aromatic hydrocarbons that have a low content of impurities and a low content of olefins and may implement high-value-addition.

Abstract: A method of controlling operation of an integrated control apparatus for autonomous vehicles includes setting one joystick lever touched first by a user between a first joystick lever and a second joystick lever to a function activation state, or setting any one joystick lever with a larger steering operation force to the function activation state at the time of steering the first joystick lever and the second joystick lever together. User fatigue when operating the joystick levers is reduced.

Abstract: Disclosed are a method and device for bidirectional communication in a wireless LAN. The method of a first STA comprises the steps of: receiving, from an AP, a first frame including an information element indicating TXOP sharing; confirming a shared TXOP duration on the basis of the first frame; and communicating with a second STA within the shared TXOP duration.

Abstract: A method and apparatus for generating late reverberation are provided. The method includes generating a reverberation parameter required to generate late reverberation based on an early room impulse response, outputting late reverberation based on the reverberation parameter, and outputting a room impulse response based on the early room impulse response and the late reverberation.

Abstract: A method and apparatus for NSTR communication in a communication system supporting multiple links are disclosed. A method for a first device comprises the steps of: if a first backoff operation has succeeded on a first link belonging to a first pair of NSTR links on which an STR operation of a second device is not supported, transmitting a first data frame to the second device on the first link; performing a second backoff operation for transmission of a second data frame on a second link belonging to the first pair of NSTR links; if the second backoff operation has succeeded on the second link, identifying whether or not a transmission operation of the second device is performed on the first link belonging to the pair of NSTR links; and transmitting the second data frame to the second device on the second link.

Abstract: A method and a device for direct communication in a communication system supporting multiple links are disclosed. A method of an AP MLD comprises the steps of: transmitting a trigger frame in multiple links including a first link and a second link; receiving a response frame for the trigger frame from a first STA associated with an STA MLD in the first link; receiving a first data frame from a third STA in the second link; and when a subject to receive the first data frame is a second STA associated with the STA MLD, transmitting a second data frame generated on the basis of the first data frame, to the first STA in the first link.

Abstract: A method for producing natural killer cells is disclosed. The method comprises isolating peripheral blood mononuclear cells (PBMCs) from a blood sample; isolating at least one of CD56+ cells and/or CD3?/CD56+ cells from the PBMCs; and co-culturing the at least one of CD56+ cells and/or CD3?/CD56+ cells with a combination of feeder cells in the presence of a cytokine. A composition for treating cancer is also disclosed. The composition comprises the CD56+ natural killer cells produced by the disclosed method and a cytokine.

Abstract: Provided are an implantable medical device control system and a control method therefor, the system comprising: an implantable medical device implanted into the body so as to stimulate a specific area in the body; a management terminal for controlling the driving of the implantable medical device by communicating with the implantable medical device through a wireless communication method; and a management server connected with the management terminal so as to be capable of communicating therewith, assigning priority to each parameter included in patient condition information and storing and managing same, and providing the stored information, and thus, since priority is assigned to each parameter included in patient 10 condition information and stimulation applied to a specific part in the body is adjusted according to the assigned priority, the entire parameter can be controlled such that a patient condition is maintained in a stabilized state by satisfying a preset reference value.

Abstract: In an embodiment a power apparatus includes a fuel cell configured to supply power to an inverter of a vehicle, a supercapacitor configured to assist the fuel cell, a bidirectional converter configured to charge and discharge the fuel cell and the supercapacitor and a controller configured to drive the vehicle by controlling the supercapacitor to be charged and discharged depending on a current required by the inverter for driving the vehicle and to assist the fuel cell.

Abstract: Provided are a crosslinked hyaluronic acid product in the form of powder and a method of preparing the same, and a crosslinked hyaluronic acid hydrogel prepared using the crosslinked hyaluronic acid product in the form of powder, and a method of preparing the same. The crosslinked hyaluronic acid hydrogel according to the present disclosure exhibits excellent rheological properties, and mass production thereof is easy and quality uniformity thereof is excellent.

Abstract: The present disclosure relates to a method and system for producing refined hydrocarbons from waste plastic pyrolysis oil. The method and system for producing refined hydrocarbons from waste plastic pyrolysis oil according to the embodiments of the present disclosure may minimize formation of an ammonium salt (NH4Cl) and may prevent an adhesion phenomenon of impurity particles in a reactor in a refining process of waste plastic pyrolysis oil containing impurities including chlorine and nitrogen. In addition, the method and system for producing refined hydrocarbons according to the embodiments of the present disclosure may have excellent refining efficiency and may implement a long-term operation of a process because deactivation of a catalyst used in the process is prevented, and may produce refined hydrocarbons having a low content of impurities and a low content of olefins from waste plastic pyrolysis oil.

Abstract: A display device may include a first pixel coupled to an emission control line, and an emission control stage for selectively coupling the emission control line to a first or second supply voltage line. The emission control stage may include: a first emission control transistor including a first electrode coupled to the first supply voltage line, a second electrode coupled to the emission control line, and a main gate electrode coupled to a first node; a second emission control transistor including a first electrode coupled to the emission control line, a second electrode coupled to the second supply voltage line, and a main gate electrode coupled to a second node; and a third emission control transistor including a first electrode coupled to the first supply voltage line, a second electrode coupled to the first node, a main gate electrode coupled to the second node, and a sub-gate electrode.

Abstract: Provided are an implantable medical device control system and a control method therefor, the system comprising: an implantable medical device implanted into the body so as to stimulate a specific area in the body; a management terminal for controlling the driving of the implantable medical device by communicating with the implantable medical device through a wireless communication method; and a management server connected with the management terminal so as to be capable of communicating therewith, assigning priority to each parameter included in patient condition information and storing and managing same, and providing the stored information, and thus, since priority is assigned to each parameter included in patient condition information and stimulation applied to a specific part in the body is adjusted according to the assigned priority, the entire parameter can be controlled such that a patient condition is maintained in a stabilized state by satisfying a preset reference value.

Abstract: An electrode assembly manufacturing apparatus includes a stack table, a separator supply unit, first and second electrode supply units, and a side sealing device. A stack of a first electrode, a second electrode, and a separator between the first and the second electrode are stackable on the stack table. The separator supply unit is configured for supplying the separator to the stack table. The first electrode supply unit is configured for stacking the first electrode on a section of the separator on the stack table. The second electrode supply unit stacks the second electrode on a further section of the separator on the first electrode. A side sealing device heats at least one side surface of the stack.

Abstract: A method and a device for shard communication in a wireless LAN are disclosed. A method of a first STA comprises the steps of: receiving a first frame for allocation of a shared communication period from an AP; identifying the shared communication period on the basis of one or more fields included in the first frame; and performing shared communication with a second STA in the shared communication period, wherein the shared communication period is configured within a TXOP configured between the AP and a third STA.

Abstract: An apparatus for estimating cardiovascular information includes: a main body; and a strap connected to the main body and formed to be flexible to be wrapped around an object, wherein the main body may include: a pulse wave measurer configured to measure, from the subject, a first pulse wave signal by using a first light of a first wavelength, and a second pulse wave signal by using a second light of a second wavelength, the first wavelength being different from the second wavelength; a contact pressure measurer configured to measure a contact pressure between the object and the pulse wave measurer; and a processor configured to extract a cardiovascular characteristic value based on the first pulse wave signal, the second pulse wave signal, and change in the contact pressure, and estimate cardiovascular information based on the extracted cardiovascular characteristic value.

Abstract: An article transfer system includes a plurality of stage modules respectively provided at a plurality of layers, an interlayer transfer apparatus configured to transfer an article to each of the plurality of stage modules, and a plurality of loading and unloading apparatus respectively provided on each stage module of the plurality of stage modules, the plurality of loading and unloading apparatus configured to load an article onto respective stage modules of the plurality of stage modules. The interlayer transfer apparatus includes a mast frame extending so as to intersect each stage module of the plurality of stage modules, and a plurality of carriage units configured to move along a length direction of the mast frame, transfer articles, and move in a parallel manner with each other.

Abstract: A non-aqueous electrolyte including an additive represented by Formula 1 is described: wherein in Formula 1, R may be any one selected from the group consisting of an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, a cycloalkyl group having 3 to 12 carbon atoms, and a cycloalkenyl group having 3 to 12 carbon atoms, R1 and R2 may each independently be any one selected from the group consisting of hydrogen (H), an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, a cycloalkyl group having 3 to 12 carbon atoms, and a cycloalkenyl group having 3 to 12 carbon atoms, and A may be an alkylene group having 1 to 5 carbon atoms.